Position in LH
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$175,280
+$10,392 QoQ
Shares Held
626
+1.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#804
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Versant Capital Management, Inc holds $4,878,585 across 26 Diagnostics & Research names. LH ranks #10 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
4,957 | $658,438 | |
| 2 | ILMN |
Illumina, Inc.
|
3,622 | $636,856 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
1,014 | $533,810 | |
| 4 | CRL |
Charles River Laboratories International, Inc.
|
1,963 | $445,188 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
2,291 | $442,667 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
858 | $430,166 | |
| 7 | RVTY |
Revvity, Inc.
|
2,280 | $253,672 | |
| 8 | NTRA |
Natera, Inc.
|
779 | $211,459 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $175,280 | 626 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $164,888 | 618 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $200,704 | 800 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $65,162 | 227 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $58,802 | 224 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $50,039 | 215 | Shares | Sole | 2025-04-03 | |
| 2024-12-31 | $47,469 | 207 | Shares | Sole | 2025-01-03 | |
| 2024-09-30 | $3,575 | 16 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $3,256 | 16 | Shares | Sole | 2024-07-08 | |
| No filing history on record for this holder in this stock. | ||||||